Castle Biosciences, Inc. - Common stock - Bilanço (NASDAQ:CSTL) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

Toplam varlıklar 439.33 M462.57 M447.33 M453.34 M531.24 M578.56 M Toplam yükümlülükler 23.64 M50.83 M48.18 M62.07 M75.4 M107.68 M Toplam özsermaye 415.69 M411.74 M399.15 M391.27 M455.83 M470.87 M Toplam yükümlülükler ve hissedarların özsermayesi 439.33 M462.57 M447.33 M453.34 M531.24 M578.56 M Toplam borç 0———9.74 M10.16 M Net borç 0———9.74 M-472.64 M

Haberler

BTIG, yüksek maliyetler nedeniyle Castle Biosciences hisse hedefini düşürdü

Castle Biosciences 1Ç 2026: Gelir beklentiyi aştı, rehberlik yükseltildi

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates

Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises

OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises

JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus

AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity Sales

Wall Street Analysts Predict an 85.15% Upside in Castle Biosciences (CSTL): Here's What You Should Know